Semantic Tech Turns Up Biomarkers And Phenotypes, Avoids Dead Ends And Higher Costs
Dr. Carlo Trugenberger, co-founder and Chief Scientific Officer at InfoCodex Semantic Technologies AG, has co-authored a report reflecting the topic he discussed at last fall’s London SemTech event: An approach to drug research that relies on identifying relevant biochemical information using the company’s autonomous self-organizing semantic engines to text mine large repositories of biomedical research papers.
The model, says Trugenberger, is a departure from many other semantically-engineered approaches to streamlining drug research, which are based on natural language processing (NLP). That’s good for extracting information from documents, he says, but not as adept at discovering knowledge. “That’s what our InfoCodex software is designed for, to find new facts and hidden correlations” in repositories of unstructured information.



The semantic technology platform behind restaurant dish discovery service
Instagram. Tumblr. Pinterest. The web in 2012 is a tremendously visual place, and yet, “visual media still as dumb today as it was 20 years ago,” says Todd Carter, founder and CEO of 
Eric Franzon
VP Community
Jennifer Zaino
Contributor
Angela Guess Contributor
semanticweb.com Twitter feed loading...